BC Week In Review | Apr 7, 2014
Company News

BioMAS, Cosmo deal

Cosmo disclosed in its 2013 earnings that on March 11, 2014, BioMAS granted Cosmo worldwide rights to all tellurium-based topical applications for all indications excluding alopecia. BioMAS received $1 million upfront and is eligible to...
BC Innovations | Jun 13, 2013
Distillery Therapeutics

Indication: Endocrine/metabolic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Infertility Phosphoinositide 3-kinase (PI3K); phosphatase and tensin homolog deleted on chromosome 10 (PTEN; MMAC1; TEP1); protein kinase B (PKB; PKBA;...
Items per page:
1 - 2 of 2